Omega 3s are on a clear path forward and will continue to trend in the nutraceutical space, according to Christopher Studte, Director New Health Ingredients, Business Line Health Care at Evonik. Studte highlights how Evonik’s omega 3 offering, AvailOm, is suitable for a wide range of solutions, as well as being three to four times more bioavailable than standard soft gel capsules. He also notes that the company is looking into supplying a vegan option, which will hopefully hit the market later this year.
Upcoming webinars

Pure love deserves a pure start: Solutions that give the best start from day one
dsm-firmenich

Magnesium bisglycinate in focus: why full chelation matters
Jungbunzlauer

Bifidobacteria and Healthy Ageing: New Insights into Ageing and Immunity
Morinaga

















